Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 120 entries
Sorted by: Best Match Show Resources per page
Diabetes mellitus.

Nursing times

McEvoy P.
PMID: 4845091
Nurs Times. 1974 Jul 11;70(28):1074-5.

No abstract available.

Cite
McEvoy P. Diabetes mellitus. Nurs Times. 1974;70(28):1074-5
McEvoy, P. (1974). Diabetes mellitus. Nursing times, 70(28), 1074-5.
McEvoy, P. "Diabetes mellitus." Nursing times vol. 70,28 (1974): 1074-5.
McEvoy P. Diabetes mellitus. Nurs Times. 1974 Jul 11;70(28):1074-5. PMID: 4845091.
Copy Download .nbib Format: NLM
A Guide to the Management of Clozapine-Related Tolerability and Safety Concerns.

Clinical schizophrenia & related psychoses

Citrome L, McEvoy JP, Saklad SR.
PMID: 27454214
Clin Schizophr Relat Psychoses. 2016 Jul 25; doi: 10.3371/CSRP.SACI.070816. Epub 2016 Jul 25.

Clozapine is a highly effective antipsychotic medication, which provides a range of significant benefits for patients with schizophrenia, and is the standard of care for treatment-resistant schizophrenia as well as for reducing the risk of suicidal behaviors in schizophrenia...

Cite
Citrome L, McEvoy JP, Saklad SR. A Guide to the Management of Clozapine-Related Tolerability and Safety Concerns. Clin Schizophr Relat Psychoses. 2016;doi: 10.3371/CSRP.SACI.070816.
Citrome, L., McEvoy, J. P., & Saklad, S. R. (2016). A Guide to the Management of Clozapine-Related Tolerability and Safety Concerns. Clinical schizophrenia & related psychoses, . https://doi.org/10.3371/CSRP.SACI.070816
Citrome, Leslie, et al. "A Guide to the Management of Clozapine-Related Tolerability and Safety Concerns." Clinical schizophrenia & related psychoses vol. (2016). doi: https://doi.org/10.3371/CSRP.SACI.070816
Citrome L, McEvoy JP, Saklad SR. A Guide to the Management of Clozapine-Related Tolerability and Safety Concerns. Clin Schizophr Relat Psychoses. 2016 Jul 25; doi: 10.3371/CSRP.SACI.070816. Epub 2016 Jul 25. PMID: 27454214.
Copy Download .nbib Format: NLM
Peter thomas fallon .

BMJ (Clinical research ed.)

McEvoy P, Cavanagh V.
PMID: 10473497
BMJ. 1999 Sep 04;319(7210):645. doi: 10.1136/bmj.319.7210.645.

No abstract available.

Cite
McEvoy P, Cavanagh V. Peter thomas fallon . BMJ. 1999;319(7210):645doi: 10.1136/bmj.319.7210.645.
McEvoy, P., & Cavanagh, V. (1999). Peter thomas fallon . BMJ (Clinical research ed.), 319(7210), 645. https://doi.org/10.1136/bmj.319.7210.645
McEvoy, and Cavanagh. "Peter thomas fallon ." BMJ (Clinical research ed.) vol. 319,7210 (1999): 645. doi: https://doi.org/10.1136/bmj.319.7210.645
McEvoy P, Cavanagh V. Peter thomas fallon . BMJ. 1999 Sep 04;319(7210):645. doi: 10.1136/bmj.319.7210.645. PMID: 10473497; PMCID: PMC1116508.
Copy Download .nbib Format: NLM
Bioaccumulation of the lipophilic metabolites of nonionic surfactants in freshwater organisms.

Environmental pollution (Barking, Essex : 1987)

Ahel M, McEvoy J, Giger W.
PMID: 15091885
Environ Pollut. 1993;79(3):243-8. doi: 10.1016/0269-7491(93)90096-7.

Nonylphenol (NP), nonlyphenol monoethoxylate (NP1EO) and nonylphenol diethoxylate (NP2EO) were determined in different freshwater organisms from the surface waters in the Glatt Valley, Switzerland. Rather high concentrations of the compounds investigated have been found to occur in macrophytic algae,...

Cite
Ahel M, McEvoy J, Giger W. Bioaccumulation of the lipophilic metabolites of nonionic surfactants in freshwater organisms. Environ Pollut. 1993;79(3):243-8doi: 10.1016/0269-7491(93)90096-7.
Ahel, M., McEvoy, J., & Giger, W. (1993). Bioaccumulation of the lipophilic metabolites of nonionic surfactants in freshwater organisms. Environmental pollution (Barking, Essex : 1987), 79(3), 243-8. https://doi.org/10.1016/0269-7491(93)90096-7
Ahel, M, et al. "Bioaccumulation of the lipophilic metabolites of nonionic surfactants in freshwater organisms." Environmental pollution (Barking, Essex : 1987) vol. 79,3 (1993): 243-8. doi: https://doi.org/10.1016/0269-7491(93)90096-7
Ahel M, McEvoy J, Giger W. Bioaccumulation of the lipophilic metabolites of nonionic surfactants in freshwater organisms. Environ Pollut. 1993;79(3):243-8. doi: 10.1016/0269-7491(93)90096-7. PMID: 15091885.
Copy Download .nbib Format: NLM
The Preventing Relational Aggression in Schools Everyday Program: A Preliminary Evaluation of Acceptability and Impact.

School psychology review

Leff SS, Waasdorp TE, Paskewich B, Gullan RL, Jawad AF, Macevoy JP, Feinberg BE, Power TJ.
PMID: 21686034
School Psych Rev. 2010 Dec;39(4):569-587.

Despite recent research suggesting that relationally aggressive behaviors occur frequently and may lead to physically aggressive actions within urban school settings, there has been little prior research to develop and evaluate relational aggression prevention efforts within the urban schools....

Cite
Leff SS, Waasdorp TE, Paskewich B, et al. The Preventing Relational Aggression in Schools Everyday Program: A Preliminary Evaluation of Acceptability and Impact. School Psych Rev. 2010;39(4):569-587
Leff, S. S., Waasdorp, T. E., Paskewich, B., Gullan, R. L., Jawad, A. F., Macevoy, J. P., Feinberg, B. E., & Power, T. J. (2010). The Preventing Relational Aggression in Schools Everyday Program: A Preliminary Evaluation of Acceptability and Impact. School psychology review, 39(4), 569-587.
Leff, Stephen S, et al. "The Preventing Relational Aggression in Schools Everyday Program: A Preliminary Evaluation of Acceptability and Impact." School psychology review vol. 39,4 (2010): 569-587.
Leff SS, Waasdorp TE, Paskewich B, Gullan RL, Jawad AF, Macevoy JP, Feinberg BE, Power TJ. The Preventing Relational Aggression in Schools Everyday Program: A Preliminary Evaluation of Acceptability and Impact. School Psych Rev. 2010 Dec;39(4):569-587. PMID: 21686034; PMCID: PMC3113534.
Copy Download .nbib Format: NLM
What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options.

The Journal of clinical psychiatry

Manning JS, McEvoy JP.
PMID: 29505191
J Clin Psychiatry. 2018 Jan/Feb;79(1). doi: 10.4088/JCP.NU16048WC3C.

Do you know which of your patients are at risk for developing tardive dyskinesia? Watch this Webcast to learn about how to prevent tardive dyskinesia in your patients and new treatment strategies for your patients who have already been...

Cite
Manning JS, McEvoy JP. What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options. J Clin Psychiatry. 2018;79(1)doi: 10.4088/JCP.NU16048WC3C.
Manning, J. S., & McEvoy, J. P. (2018). What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options. The Journal of clinical psychiatry, 79(1), . https://doi.org/10.4088/JCP.NU16048WC3C
Manning, J Sloan, and McEvoy, Joseph P. "What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options." The Journal of clinical psychiatry vol. 79,1 (2018). doi: https://doi.org/10.4088/JCP.NU16048WC3C
Manning JS, McEvoy JP. What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options. J Clin Psychiatry. 2018 Jan/Feb;79(1). doi: 10.4088/JCP.NU16048WC3C. PMID: 29505191.
Copy Download .nbib Format: NLM
Blinding Strategies in Dry Needling Trials: Systematic Review and Meta-Analysis.

Physical therapy

Braithwaite FA, Walters JL, Li LSK, Moseley GL, Williams MT, McEvoy MP.
PMID: 31373369
Phys Ther. 2019 Nov 25;99(11):1461-1480. doi: 10.1093/ptj/pzz111.

BACKGROUND: Blinding of participants and therapists in trials of physical interventions is a significant and ongoing challenge. There is no widely accepted sham protocol for dry needling.PURPOSE: The purpose of this review was to summarize the effectiveness and limitations...

Cite
Braithwaite FA, Walters JL, Li LSK, et al. Blinding Strategies in Dry Needling Trials: Systematic Review and Meta-Analysis. Phys Ther. 2019;99(11):1461-1480doi: 10.1093/ptj/pzz111.
Braithwaite, F. A., Walters, J. L., Li, L. S. K., Moseley, G. L., Williams, M. T., & McEvoy, M. P. (2019). Blinding Strategies in Dry Needling Trials: Systematic Review and Meta-Analysis. Physical therapy, 99(11), 1461-1480. https://doi.org/10.1093/ptj/pzz111
Braithwaite, Felicity A, et al. "Blinding Strategies in Dry Needling Trials: Systematic Review and Meta-Analysis." Physical therapy vol. 99,11 (2019): 1461-1480. doi: https://doi.org/10.1093/ptj/pzz111
Braithwaite FA, Walters JL, Li LSK, Moseley GL, Williams MT, McEvoy MP. Blinding Strategies in Dry Needling Trials: Systematic Review and Meta-Analysis. Phys Ther. 2019 Nov 25;99(11):1461-1480. doi: 10.1093/ptj/pzz111. PMID: 31373369.
Copy Download .nbib Format: NLM
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future.

Neuropsychiatric disease and treatment

Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ.
PMID: 31564881
Neuropsychiatr Dis Treat. 2019 Sep 05;15:2559-2569. doi: 10.2147/NDT.S209284. eCollection 2019.

Olanzapine is a second-generation atypical antipsychotic with proven efficacy for the treatment of schizophrenia. Approved in 1996, olanzapine is one of the most studied antipsychotics, resulting in a considerable amount of clinical data across diverse patient populations. Despite the...

Cite
Citrome L, McEvoy JP, Todtenkopf MS, et al. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatr Dis Treat. 2019;15:2559-2569doi: 10.2147/NDT.S209284.
Citrome, L., McEvoy, J. P., Todtenkopf, M. S., McDonnell, D., & Weiden, P. J. (2019). A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatric disease and treatment, 152559-2569. https://doi.org/10.2147/NDT.S209284
Citrome, Leslie, et al. "A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future." Neuropsychiatric disease and treatment vol. 15 (2019): 2559-2569. doi: https://doi.org/10.2147/NDT.S209284
Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatr Dis Treat. 2019 Sep 05;15:2559-2569. doi: 10.2147/NDT.S209284. eCollection 2019. PMID: 31564881; PMCID: PMC6733343.
Copy Download .nbib Format: NLM
Is TCC-EZ a Suitable Alternative to Gold Standard Total-Contact Casting?.

Journal of the American Podiatric Medical Association

Bhatt UK, Foo HY, McEvoy MP, Tomlinson SJ, Westphal C, Harrison JC, Oshin O, Carter SL.
PMID: 34861683
J Am Podiatr Med Assoc. 2021 Sep 01;111(5). doi: 10.7547/8750-7315-111-5.Article_1.

BACKGROUND: The total-contact cast (TCC) is the gold standard for off-loading diabetic foot ulcers (DFUs) given its nonremovable nature. However, this modality remains underused in clinical settings due to the time and experience required for appropriate application. The TCC-EZ...

Cite
Bhatt UK, Foo HY, McEvoy MP, et al. Is TCC-EZ a Suitable Alternative to Gold Standard Total-Contact Casting?. J Am Podiatr Med Assoc. 2021;111(5)doi: 10.7547/8750-7315-111-5.Article_1.
Bhatt, U. K., Foo, H. Y., McEvoy, M. P., Tomlinson, S. J., Westphal, C., Harrison, J. C., Oshin, O., & Carter, S. L. (2021). Is TCC-EZ a Suitable Alternative to Gold Standard Total-Contact Casting?. Journal of the American Podiatric Medical Association, 111(5), . https://doi.org/10.7547/8750-7315-111-5.Article_1
Bhatt, Umangi K, et al. "Is TCC-EZ a Suitable Alternative to Gold Standard Total-Contact Casting?." Journal of the American Podiatric Medical Association vol. 111,5 (2021). doi: https://doi.org/10.7547/8750-7315-111-5.Article_1
Bhatt UK, Foo HY, McEvoy MP, Tomlinson SJ, Westphal C, Harrison JC, Oshin O, Carter SL. Is TCC-EZ a Suitable Alternative to Gold Standard Total-Contact Casting?. J Am Podiatr Med Assoc. 2021 Sep 01;111(5). doi: 10.7547/8750-7315-111-5.Article_1. PMID: 34861683.
Copy Download .nbib Format: NLM
Insomnia and triglycerides in schizophrenia.

Schizophrenia research

Miller BJ, McEvoy JP, McCall WV, Harris RA.
PMID: 34839072
Schizophr Res. 2021 Nov 25;239:42-43. doi: 10.1016/j.schres.2021.11.021. Epub 2021 Nov 25.

No abstract available.

Cite
Miller BJ, McEvoy JP, McCall WV, et al. Insomnia and triglycerides in schizophrenia. Schizophr Res. 2021;239:42-43doi: 10.1016/j.schres.2021.11.021.
Miller, B. J., McEvoy, J. P., McCall, W. V., & Harris, R. A. (2021). Insomnia and triglycerides in schizophrenia. Schizophrenia research, 23942-43. https://doi.org/10.1016/j.schres.2021.11.021
Miller, Brian J, et al. "Insomnia and triglycerides in schizophrenia." Schizophrenia research vol. 239 (2021): 42-43. doi: https://doi.org/10.1016/j.schres.2021.11.021
Miller BJ, McEvoy JP, McCall WV, Harris RA. Insomnia and triglycerides in schizophrenia. Schizophr Res. 2021 Nov 25;239:42-43. doi: 10.1016/j.schres.2021.11.021. Epub 2021 Nov 25. PMID: 34839072.
Copy Download .nbib Format: NLM
Isolated Diastolic Hypertension in the IDACO Study: An Age-Stratified Analysis Using 24-Hour Ambulatory Blood Pressure Measurements.

Hypertension (Dallas, Tex. : 1979)

McEvoy JW, Yang WY, Thijs L, Zhang ZY, Melgarejo JD, Boggia J, Hansen TW, Asayama K, Ohkubo T, Dolan E, Stolarz-Skrzypek K, Malyutina S, Casiglia E, Lind L, Filipovský J, Maestre GE, Li Y, Wang JG, Imai Y, Kawecka-Jaszcz K, Sandoya E, Narkiewicz K, O'Brien E, Vanassche T, Staessen JA.
PMID: 34601965
Hypertension. 2021 Nov;78(5):1222-1231. doi: 10.1161/HYPERTENSIONAHA.121.17766. Epub 2021 Oct 04.

[Figure: see text].

Cite
McEvoy JW, Yang WY, Thijs L, et al. Isolated Diastolic Hypertension in the IDACO Study: An Age-Stratified Analysis Using 24-Hour Ambulatory Blood Pressure Measurements. Hypertension. 2021;78(5):1222-1231doi: 10.1161/HYPERTENSIONAHA.121.17766.
McEvoy, J. W., Yang, W. Y., Thijs, L., Zhang, Z. Y., Melgarejo, J. D., Boggia, J., Hansen, T. W., Asayama, K., Ohkubo, T., Dolan, E., Stolarz-Skrzypek, K., Malyutina, S., Casiglia, E., Lind, L., Filipovský, J., Maestre, G. E., Li, Y., Wang, J. G., Imai, Y., Kawecka-Jaszcz, K., Sandoya, E., Narkiewicz, K., O'Brien, E., Vanassche, T., Staessen, J. A. (2021). Isolated Diastolic Hypertension in the IDACO Study: An Age-Stratified Analysis Using 24-Hour Ambulatory Blood Pressure Measurements. Hypertension (Dallas, Tex. : 1979), 78(5), 1222-1231. https://doi.org/10.1161/HYPERTENSIONAHA.121.17766
McEvoy, John W, et al. "Isolated Diastolic Hypertension in the IDACO Study: An Age-Stratified Analysis Using 24-Hour Ambulatory Blood Pressure Measurements." Hypertension (Dallas, Tex. : 1979) vol. 78,5 (2021): 1222-1231. doi: https://doi.org/10.1161/HYPERTENSIONAHA.121.17766
McEvoy JW, Yang WY, Thijs L, Zhang ZY, Melgarejo JD, Boggia J, Hansen TW, Asayama K, Ohkubo T, Dolan E, Stolarz-Skrzypek K, Malyutina S, Casiglia E, Lind L, Filipovský J, Maestre GE, Li Y, Wang JG, Imai Y, Kawecka-Jaszcz K, Sandoya E, Narkiewicz K, O'Brien E, Vanassche T, Staessen JA. Isolated Diastolic Hypertension in the IDACO Study: An Age-Stratified Analysis Using 24-Hour Ambulatory Blood Pressure Measurements. Hypertension. 2021 Nov;78(5):1222-1231. doi: 10.1161/HYPERTENSIONAHA.121.17766. Epub 2021 Oct 04. PMID: 34601965; PMCID: PMC8516806.
Copy Download .nbib Format: NLM
A novel blinding protocol to test participant and therapist blinding during dry needling: a randomised controlled experiment.

Physiotherapy

Braithwaite FA, Walters JL, Moseley GL, Williams MT, McEvoy MP.
PMID: 34579950
Physiotherapy. 2021 Dec;113:188-198. doi: 10.1016/j.physio.2021.08.007. Epub 2021 Aug 25.

OBJECTIVES: Dry needling is widely used in physiotherapy. Lack of blinding in clinical trials means that dry needling effects and mechanisms remain unclear, with blinding issues accepted as an unavoidable barrier to better evidence. The authors aimed to overcome...

Cite
Braithwaite FA, Walters JL, Moseley GL, et al. A novel blinding protocol to test participant and therapist blinding during dry needling: a randomised controlled experiment. Physiotherapy. 2021;113:188-198doi: 10.1016/j.physio.2021.08.007.
Braithwaite, F. A., Walters, J. L., Moseley, G. L., Williams, M. T., & McEvoy, M. P. (2021). A novel blinding protocol to test participant and therapist blinding during dry needling: a randomised controlled experiment. Physiotherapy, 113188-198. https://doi.org/10.1016/j.physio.2021.08.007
Braithwaite, Felicity A, et al. "A novel blinding protocol to test participant and therapist blinding during dry needling: a randomised controlled experiment." Physiotherapy vol. 113 (2021): 188-198. doi: https://doi.org/10.1016/j.physio.2021.08.007
Braithwaite FA, Walters JL, Moseley GL, Williams MT, McEvoy MP. A novel blinding protocol to test participant and therapist blinding during dry needling: a randomised controlled experiment. Physiotherapy. 2021 Dec;113:188-198. doi: 10.1016/j.physio.2021.08.007. Epub 2021 Aug 25. PMID: 34579950.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 120 entries